Keywords: hgs, get, 40m, milestone, novartis, albuferon, usa-based
HGS to get $40M milestone from Novartis for Albuferon
Article | 03 September 2007
USA-based Human Genome Sciences will receive a $40.0 million payment from Swiss drug major Novartis in September for the previously-reported successful ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscribe now
for unlimited access to all articles
Subscriptions are £60 per month, pay as you go.
Find out more details.
Already a subscriber? Click here to log in
- Boehringer Ingelheim gets FDA warning letter on cGMP failures
- AstraZeneca's naloxegol meets endpoints; EMA validates Gilead's sofosbuvir MAA
- Is failure to adopt business process management putting the pharma industry at risk?
- Sanofi and Regeneron's dupilumab shows 87% reduction in risk of asthma exacerbations
- Pfizer to split-off remaining 80% interest in Zoetis
